Snap Chart

A Big Bounceback for Healthcare Private Equity

The industry logged records for the number of deals and disclosed value in 2021, and competition for deals should intensify.

Snap Chart

A Big Bounceback for Healthcare Private Equity
en

In the second year of Covid-19, healthcare private equity activity showed remarkable resilience to the widespread disruption, posting a record year for both deal volume and disclosed value. This stemmed partly from a pandemic-induced backlog of parked deals, as well as the revival of megadeals. Competition looks set to intensify, following the record number of healthcare-focused funds initiated in 2021 and total capital raised. Major trends include these:

  • the consumerization of care;
  • digital solutions that improve operational efficiency;
  • a willingness to take on drug development risk;
  • large transactions in European biopharma and life sciences tools; and
  • an even higher baseline for deals in Asia-Pacific.

     

Read the Related Report

Healthcare Private Equity Market 2021: The Year in Review

The industry roared back after a pandemic-induced lull in 2020.

Markierungen
Markierungen

Möchten Sie mit uns in Kontakt bleiben?

Wir unterstützen Führungskräfte weltweit, die kritischen Themen in ihrem Unternehmen zu adressieren. Gemeinsam schaffen wir nachhaltige Veränderungen und Ergebnisse.